Innovator’s Pitch Challenge

Interested in Connecting? Please contact:
Bill Densel
President and CEO
bill.densel@pneumatx.com

Message the company or request a 1:1 meeting here

Pneuma Therapeutics aspires to develop and commercialize non-invasive ventilation therapies based on its proprietary XChange™ Nasal Positive Pressure Ventilation System and µGap Valve™ Intelligent Gas Source technologies for procedural oxygenation and ventilation, respiratory insufficiency, and obstructive sleep apnea. The Company’s first product, the XChange™ System, targets the prevention of hypoxemia during the perioperative period.